Journal of Health Care and Research
Article Type: Commentary
J Health Care and Research. 2021 Jul 02;2(2):122-25
1Medical Research/Tokushima University, Tokushima, Japan
2Japan Low Carbohydrate Diet Promotion Association, (JLCDPA), Kyoto, Japan
Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ORCID iD
Address: Tokushima University /Medical Research, Nakashowa 1 61, Tokushima 770 0943, Japan.
Received date: 16 June 2021; Accepted date: 26 June 2021; Published date: 02 July 2021
Citation: Bando H. Perspectives on Sarcopenia and Protein Intake in Aged and Diabetic Patients. J Health Care and Research. 2021 Jul 02;2(2):122-25.
Copyright © 2021 Bando H. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Keywords: Sarcopenia, Asian Working Group for Sarcopenia (AWGS) 2019, Protein Intake, Sodium/Glucose Cotransporter 2 Inhibitors (SGLT2i), Low Carbohydrate Diet (LCD)
Abbreviations: AWGS: Asian Working Group for Sarcopenia; SGLT2i: Sodium/Glucose Cotransporter 2 Inhibitors; LCD: Low Carbohydrate Diet
The relationship among sarcopenia, protein intake, elderly, and diabetes has been in discussion. The Asian Working Group for Sarcopenia (AWGS) 2019 has revised the content by emphasizing the 5-time chair stand test. For prevention and treatment of sarcopenia and frailty, continuous protein intake is required such as meat, eggs, tofu, and so on. Elderly aged >65 is recommended to take at least >1.0 g/kg weight of protein per day for preventing sarcopenia and frailty. Sodium/glucose cotransporter-2 inhibitors (SGLT2i) have been widely used. However, SGLT2i are advised not to provide the subjects who are elderly and/or with sarcopenia or senile syndrome.